ITF Therapeutics LLC’s Post

ITF Therapeutics LLC reposted this

Italfarmaco is proud to sponsor an ISPOR Educational Webinar on December 4th 2024, titled: “Leveraging the Value of Clinical Outcomes in DMD for Decision Making”. The webinar will be moderated by Dr. Francois Meyer and will include talks from three highly distinguished experts in DMD: Prof. Valeria Sansone; Conny Pelicaen and Dr. Paolo Bettica. Don’t miss the opportunity to gain insights into DMD, from understanding disease progression to navigating key disease milestones, as well as the complexities of clinical trial design in this therapeutic area. Discover the importance of collaboration among patient advocates, clinicians, and industry to improve patient access to innovative treatments. Italfarmaco’s rare diseases mission is to bring new opportunities to the rare diseases community, with innovation, quality, knowledge and motivation that can help more people su­ffering from rare diseases, than ever before. For additional information: https://lnkd.in/epmWhwBm

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics